1. Home
  2. SPPL vs DARE Comparison

SPPL vs DARE Comparison

Compare SPPL & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SPPL

SIMPPLE LTD.

HOLD

Current Price

$2.51

Market Cap

23.7M

Sector

N/A

ML Signal

HOLD

Logo Dare Bioscience Inc.

DARE

Dare Bioscience Inc.

HOLD

Current Price

$2.38

Market Cap

21.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPPL
DARE
Founded
2016
2015
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.7M
21.6M
IPO Year
2022
2014

Fundamental Metrics

Financial Performance
Metric
SPPL
DARE
Price
$2.51
$2.38
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$10.00
AVG Volume (30 Days)
1.3M
671.9K
Earning Date
04-08-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,807,885.00
Revenue This Year
N/A
$2,115.12
Revenue Next Year
N/A
$122.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.50
$1.27
52 Week High
$7.00
$9.19

Technical Indicators

Market Signals
Indicator
SPPL
DARE
Relative Strength Index (RSI) 64.13 57.53
Support Level $2.51 $1.79
Resistance Level $3.63 $2.54
Average True Range (ATR) 0.14 0.34
MACD 0.07 -0.02
Stochastic Oscillator 95.45 36.36

Price Performance

Historical Comparison
SPPL
DARE

About SPPL SIMPPLE LTD.

Simpple Ltd delivers an ecosystem solution that combines Internet-of-Things devices, robotic solutions, and an integrated software system operating in unison to position buildings to be future-ready. The company operates through two primary segments: the sale, warranty, and maintenance of autonomous robotic cleaning equipment (Robots), and the sale of facilities management software (Facilities management software). The majority of its revenue is generated from the Robots segment. The company has expanded its operations into Australia /New Zealand and may also enter or expand in other geographic markets such as Canada, Hong Kong, Japan, the Middle East, the United Kingdom, Europe and the United States.

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

Share on Social Networks: